Brussels, 08/05/2012 (Agence Europe) - On Tuesday 8 May, the European Commission concluded that €23 million of public funding, which Italy intends to grant to Novartis Vaccines & Diagnostics S.r.l. (NV&D) for the research and development of innovative vaccines, is in line with EU state aid rules - in particular because it tackles a genuine market failure and stimulates research in the EU. The project aims at ensuring that developing countries gain quicker access to such innovative products...